Emulsion preventer for completion brines

US10537829B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10537829-B2
Application numberUS-201615296505-A
CountryUS
Kind codeB2
Filing dateOct 18, 2016
Priority dateOct 20, 2015
Publication dateJan 21, 2020
Grant dateJan 21, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Emulsion-preventing compositions may contain one or more sorbitan esters; and one or more non-ionic surfactants; where the ratio of the one or more sorbitan esters to the one or more non-ionic surfactants is in the range of 1:1 to 1:5. Methods may include contacting an emulsion with a treatment fluid, the treatment fluid containing one or more sorbitan esters and one or more non-ionic surfactants, where the ratio of the one or more sorbitan esters to the one or more non-ionic surfactants is in the range of 1:1 to 1:5; and separating the emulsion into an aqueous phase and an oleaginous phase.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising: emplacing a wellbore fluid into a wellbore, the wellbore fluid comprising: a base fluid; one or more sorbitan esters; and one or more nonionic surfactants; wherein the volumetric ratio of the one or more sorbitan esters to the one or more nonionic surfactants is in the range of 1:1 to 1:5, wherein the wellbore fluid meets at least two of the following three criteria: (1) Biodegradation a) >60% in 28 days as measured by OECD 306 or any other OSPAR-accepted marine protocols, b) or in the absence of valid results for such tests: i. >60% in 28 days as measured by OECD 301B, 301C, 301D, 301F, 310, Freshwater BODIS or ii. >70% in 28 days as measured by OECD 301A, 301E; (2) Bioaccumulation a) a bioconcentration factor of less than 100; b) log P ow ≤3 and molecular weight>700, or c) if the conclusion of a weight of evidence expert judgment under Appendix 3 of OSPAR Agreement 2008-5 is positive; and (3) Aquatic Toxicity a) LC 50 >10 mg/l or EC 50 >10 mg/l. 2. The method of claim 1 , further comprising: contacting the wellbore fluid with an emulsion in the wellbore; and demulsifying the emulsion into an aqueous phase and an oleaginous phase. 3. The method of claim 1 , wherein the one or more sorbitan esters are selected from one or more of a group consisting of alkoxylated sorbitan esters, polysorbates, and sorbitans esterified with mono-, di-, tri-, or tetra-esters of C8-C22 alkyl or alkenyl fatty acids. 4. The method of claim 1 , wherein the one or more nonionic surfactants are alkyl glycosides of the general formula: where X is a number from 1 to 4; and Y ranges from 4 to 25. 5. The method of claim 1 , wherein the wellbore fluid further comprises a mutual solvent. 6. A method comprising: contacting an emulsion with a treatment fluid, the treatment fluid comprising: one or more sorbitan esters, and one or more nonionic surfactants, wherein the volumetric ratio of the one or more sorbitan esters to the one or more nonionic surfactants is in the range of 1:1 to 1:5; and separating the emulsion into an aqueous phase and an oleaginous phase, wherein the treatment fluid meets at least two of the following three criteria: (1) Biodegradation a) >60% in 28 days as measured by OECD 306 or any other OSPAR-accepted marine protocols, b) or in the absence of valid results for such tests: i. >60% in 28 days as measured by OECD 301B, 301C, 301D, 301F, 310, Freshwater BODIS or ii. >70% in 28 days as measured by OECD 301A, 301E; (2) Bioaccumulation a) a bioconcentration factor of less than 100; b) log P ow ≤3 and molecular weight >700, or c) if the conclusion of a weight of evidence expert judgment under Appendix 3 of OSPAR Agreement 2008-5 is positive; and (3) Aquatic Toxicity a) LC 50 >10 mg/l or EC 50 >10 mg/l. 7. The method of claim 6 , further comprising: isolating the separated aqueous phase; and injecting the separated aqueous phase into a wellbore. 8. The method of claim 6 , wherein the one or more sorbitan esters are selected from one or more of a group consisting of alkoxylated sorbitan esters, polysorbates, and sorbitans esterified with mono-, di-, tri-, or tetra-esters of C8-C22 alkyl or alkenyl fatty acids. 9. The method of claim 6 , wherein the one or more nonionic surfactants are alkyl glycosides of the general formula: where X is a number from 1 to 4; and Y ranges from 4 to 25. 10. The method of claim 6 , wherein the treatment fluid further comprises a mutual solvent. 11. The method of claim 6 , wherein the treatment fluid comprises a mutual solvent at a concentration within the range of 0.1 vol % to about 50 vol %. 12. A method, comprising: emplacing a wellbore fluid into a wellbore, the wellbore fluid comprising: a base fluid; a surfactant package comprising: one or more sorbitan esters present in the surfactant package in an amount ranging from about 5 to about 50 vol % of the surfactant package; and one or more nonionic surfactants present in the surfactant package in an amount ranging from about 50 to about 95 vol % of the surfactant package, the one or more nonionic surfactants comprising at least an alkyl glycoside of the general formula: where X is a number from 1 to 4; and Y ranges from 4 to 25. 13. The method of claim 12 , wherein the wellbore fluid meets at least two of the following three criteria: (1) Biodegradation a) >60% in 28 days as measured by OECD 306 or any other OSPAR-accepted marine protocols, b) or in the absence of valid results for such tests: i. >60% in 28 days as measured by OECD 301B, 301C, 301D, 301F, 310, Freshwater BODIS or ii. >70% in 28 days as measured by OECD 301A, 301E; (2) Bioaccumulation a) a bioconcentration factor of less than 100; b) log P ow ≤3 and molecular weight >700, or c) if the conclusion of a weight of evidence expert judgment under Appendix 3 of OSPAR Agreement 2008-5 is positive; and (3) Aquatic Toxicity a) LC 50 >10 mg/l or EC 50 >10 mg/l. 14. The method of claim 12 , further comprising: contacting the wellbore fluid with an emulsion in the wellbore; and demulsifying the emulsion into an aqueous phase and an oleaginous phase.

Assignees

Inventors

Classifications

  • Emulsions · CPC title

  • from quarries or from mining activities · CPC title

  • B01D17/047Primary

    with separation aids · CPC title

  • Devices for dosing liquid additives · CPC title

  • characterised by the use of specific surfactants · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10537829B2 cover?
Emulsion-preventing compositions may contain one or more sorbitan esters; and one or more non-ionic surfactants; where the ratio of the one or more sorbitan esters to the one or more non-ionic surfactants is in the range of 1:1 to 1:5. Methods may include contacting an emulsion with a treatment fluid, the treatment fluid containing one or more sorbitan esters and one or more non-ionic surfactan…
Who is the assignee on this patent?
Mi Llc
What technology area does this patent fall under?
Primary CPC classification B01D17/047. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).